Konverge Plus 20 mg / 5 mg / 12.5 mg film-coated tablets
- Licence status
- Withdrawn: 31/01/2022
- Active substances
- Hydrochlorothiazide, Olmesartan medoxomil, Amlodipine
- Dosage Form
- Film-coated tablet
- Licence number
- PPA0465/421/001
- Licence holder
- PCO Manufacturing Ltd.
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- C09DX Angiotensin II antagonists, other combinations, C09DX03 olmesartan medoxomil, amlodipine and hydrochlorothiazide
- Legal supply status
- Product subject to prescription which may be renewed (B)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 20/01/2017